MANILA, PHILIPPINES — Procter & Gamble (P&G) Philippines, the multinational company behind the trusted personal healthcare brands such as Vicks, Neurobion, Dolo-Neurobion, and Sangobion, was recognized for its product and marketing superiority in the healthcare and pharmaceutical sectors at the recent 2023 Monthly Index of Medical Specialties (MIMS) Excellence Awards.
The MIMS Excellence Awards honors the most innovative and effective brands, products, and initiatives in the Philippine healthcare and pharmaceutical industries. The awards cover a wide range of achievements and excellence in areas ranging from brand management, marketing, publications, campaigns, online and in-person events, drug listings, and more.
P&G Philippines’ Award Highlights:
- Neurobion – Bronze Awardee for Best Brand Category: This award recognizes the outstanding brand as determined by the best-in-class marketing programs, delivered projects, collaborations, and the number of touchpoints achieved.
- Dr. Digna “Didi” Almeida – Gold Awardee for Best Medical Manager Category: This award recognizes the outstanding achievements in medical communications programs determined by the delivered projects, collaborations, and the number of touchpoints achieved.
- P&G Nerve Care Summit – Gold Awardee for Best Pioneering Award Category: This award recognizes the innovative spirit of pioneering projects in the healthcare and pharmaceutical industries.
“P&G Philippines’ accolades at the 2023 MIMS Excellence Awards are a testament to the company’s continued commitment to delivering impactful collaborations, transformative brand marketing programs, and meaningful medical communication projects. These awards affirm our dedication to providing personal healthcare products of the highest quality and superior performance, meeting the daily-use health needs of our consumers throughout the country,” said Ming Arroyo-Cunanan, P&G’s Senior Director for Personal Health Care Category.
